April 8, 2020 Clinical Research/Diagn. Informatics & Software

Global COVID-19 Clinical Trial Tracker launched by Cytel

Caption: Global COVID-19 Clinical Trial Tracker Waltham, MA — April 08, 2020 — Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak. This will enable... Read more

April 7, 2020 Clinical Research/Diagn. Product Launch

Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies

Date: 04/07/2020 HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Preliminary performance of the assay has been established and the... Read more

April 3, 2020 Clinical Research/Diagn.

BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.

New Test Immediately Available to Increase Capacity of Rapid, On-Site Testing of COVID-19 at Hospitals Across the U.S.Apr 3, 2020 FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala. April 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S.... Read more

April 1, 2020 Clinical Research/Diagn. Life Science Tools

Promega GoTaq® Probe 1-Step RT-qPCR System Approved for Use in CDC’s COVID-19 Emergency Use Authorization Diagnostic Panel

Promega amplification reagent added to EUA list for laboratories that follow CDC’s testing protocols Madison, WI USA. (April 1, 2020) Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus... Read more

April 1, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!

April 1, 2020 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched its new AAV stability application on the Uncle platform today. Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit... Read more

April 1, 2020 Clinical Research/Diagn. Product Launch

Miltenyi Biotec launches new tool for coronavirus-specific T cell research

Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2BERGISCH GLADBACH, April 01, 2020 – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide... Read more

April 1, 2020 Clinical Research/Diagn. Life Science Tools

SCIEX Debuts Breakthrough Method for Gene Therapies

Robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis April 01, 2020 Framingham, MA — SCIEX, a global leader in life science analytical technologies, launched an exciting new method for streamlining and improving the production of gene therapies. This innovative capillary electrophoretic method addresses a key customer challenge by analyzing AAVs... Read more

March 31, 2020 Clinical Research/Diagn. Product Launch

BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

Point-of-care blood test detects evidence of present or past exposure in 15 minutesMar 31, 2020 FRANKLIN LAKES, N.J. MORRISVILLE, N.C., March 31, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, today announced the release of a new point-of-care... Read more

March 30, 2020 Clinical Research/Diagn. M&A, Partnerships

Promega Part of New Wisconsin Public-Private Partnership to Increase COVID-19 Laboratory Testing Capacity

Madison, WI USA. (March 30, 2020) Promega Corporation is part of a new public-private partnership among Wisconsin industry leaders to increase the state’s laboratory testing capacity for COVID-19. Wisconsin Governor Tony Evers made the announcement today. The expanded capacity from this new partnership is expected to initially double testing capacity in Wisconsin, currently averaging 1,500-2,000 COVID-19 tests... Read more

March 26, 2020 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19 WALTHAM, Mass., March 26, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the... Read more